INanoBio presenting at PMWC
INanoBio CEO, Bharath Takulapalli will be presenting at the Precision Medicine World Conference 2022 at the Santa Clara Convention Center.
INanoBio at MSTC 2022
INanoBio CEO, Bharath Takulapalli to speak at the MEMS & Sensors Technical Congress to be held at the David Brower Center in Berkeley.
Genomeweb Coverage of FENT Prototype Development
Nanopore Sequencing Firm iNanoBio Says Fast Sensor Will Result in Speedy Platform
FENT Prototype Development
Genomeweb on DARPA ECHO Award
INanoBio Nabs $5.4M From DARPA for Silicon Nanopore Sequencer Development
DARPA ECHO PROGRAM
INanoBio awarded up to $5.4 Million to develop an Epigenetic Sequencer under the DARPA ECHO Program.
INanoBio Expands Board
Dr. Abhay Sanan and JP Million join INanoBio Board of Directors as part of 2018 Series Seed financing
NIH SBIR GRANT
INanoBio awarded $0.7 M grant by National Institute of Health (NIH) to develop an advanced automated system for high throughput proteomic assays.
IEEE VLSI TSA Keynote
INanoBio CEO Bharath Takulapalli to Keynote IEEE VLSI TSA conference in Taiwan.
Nature.com Webcast
INanoBio participates in Nature.com webcast on ‘Advances in Precision Medicine and Genomic Sequencing’.
Prof. Chenming Hu joins INanoBio’s SAB
Prof. Chenming Hu, inventor of FINFET or 3D transistor & Microelectronics Visionary has joined INanoBio’s Scientific Advisory Board.
Prof. George Church to chair iNanoBio SAB
Genomics pioneer Prof. George Church of Harvard Medical School will chair INanoBio’s Scientific Advisory Board.
JP Millon joins iNanoBio Advisory Board
Former CEO of PCS Health JP Millon, who is currently on the Board of CVS Health has joined INanoBio’s Advisory Board.
